HuD impairs neuromuscular junctions and induces apoptosis in human iPSC and Drosophila ALS models.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 39511225.
- Also identified by DOI 10.1038/s41467-024-54004-8 and PMC identifier 11544248.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Defects at the neuromuscular junction (NMJ) are among the earliest hallmarks of amyotrophic lateral sclerosis (ALS). According to the "dying-back" hypothesis, NMJ disruption not only precedes but also triggers the subsequent degeneration of motoneurons in both sporadic (sALS) and familial (fALS) ALS. Using human induced pluripotent stem cells (iPSCs), we show that the RNA-binding protein HuD (ELAVL4) contributes to NMJ defects and apoptosis in FUS-ALS. HuD overexpression mimics the severe FUS<sup>P525L</sup> mutation, while its knockdown rescues the FUS<sup>P525L</sup> phenotypes. In Drosophila, neuronal overexpression of the HuD ortholog, elav, induces motor dysfunction, and its knockdown improves motor function in a FUS-ALS model. Finally, we report increased HuD levels upon oxidative stress in human motoneurons and in sALS patients with an oxidative stress signature. Based on these findings, we propose that HuD plays a role downstream of FUS mutations in fALS and in sALS related to oxidative stress.
Medical subject headings
- Neuromuscular Junction
- Amyotrophic Lateral Sclerosis
- Apoptosis
- Induced Pluripotent Stem Cells
- Motor Neurons
- RNA-Binding Protein FUS
- Disease Models, Animal
- ELAV-Like Protein 4